A Review of the Compatibility of Liposome Bupivacaine with Other Drug Products and Commonly Used Implant Materials

References

• . Newton DW. Crux of drug compatibility and incompatibility. Am J Health Syst Pharm. 2010;67(2):108, 112
   PubMedGoogle Scholar
• . Bergese SD, Ramamoorthy S, Patou G, Bramlett K, Gorfine SR, Candiotti KA. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res. 2012;5:107–116
   PubMedGoogle Scholar
• . Exparel [package insert]. Parsippany, NJ: Pacira Pharmaceuticals, Inc.; 2011
   Google Scholar
• . Richard BM, Ott LR, Haan D, . The safety and tolerability evaluation of DepoFoam bupivacaine (bupivacaine extended-release liposome injection) administered by incision wound infiltration in rabbits and dogs. Expert Opin Investig Drugs. 2011;20(10):1327–1341
   PubMed Web of Science ®Google Scholar
• . Richard BM, Rickert DE, Doolittle D, Mize A, Liu J, Lawson CF. Pharmacokinetic compatibility study of lidocaine with EXPAREL in Yucatan miniature pigs. ISRN Pharmaceutics. 2011;2011:582351
   PubMedGoogle Scholar
• . Richard BM, Newton P, Ott LR, . The safety of EXPAREL (bupivacaine liposome injectable suspension) administered by peripheral nerve block in rabbits and dogs. J Drug Deliv. 2012;2012:962101
   PubMedGoogle Scholar
• . Langford RM, Chappell GM, Karrasch JA. A single administration of DepoBupivacaine intraoperatively results in prolonged detectable plasma bupivacaine and analgesia in patients undergoing inguinal hernia repair [abstract P-9088]. Presented at: Annual Postgraduate Assembly in Anesthesiology of the New York State Society of Anesthesiologists; December 12–16, 2008; New York, NY
   Google Scholar
• . Haas E, Onel E, Miller H, Ragupathi M, White PF. A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg. 2012;78(5):574–581
   PubMed Web of Science ®Google Scholar
• . White PF, Schooley GL, Ardeleanu M. Analgesia following a single administration of depobupivacaine intraoperatively in patients undergoing inguinal herniorrhaphy: preliminary dose-ranging studies [abstract S-242]. Anesth Analg. 2009;108( Suppl 3S):S242
   Google Scholar
• . Bramlett K, Onel E, Viscusi ER, Jones K. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee. 2012;19(5):530–536
   PubMed Web of Science ®Google Scholar
• . Smoot JD, Bergese SD, Onel E, Williams HT, Hedden W. The efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammoplasty: a randomized, double-blind, active-control study. Aesthet Surg J. 2012;32(1):69–76
   PubMed Web of Science ®Google Scholar
• . Gorfine SR, Onel E, Patou G, Krivokapic ZV. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2011;54(12):1552–1559
   PubMed Web of Science ®Google Scholar
• . Golf M, Daniels SE, Onel E. A phase 3, randomized, placebo-controlled trial of DepoFoam bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther. 2011;28(9):776–788
   PubMed Web of Science ®Google Scholar
• . Dasta J, Ramamoorthy S, Patou G, Sinatra R. Bupivacaine liposome injectable suspension compared with bupivacaine HCl for the reduction of opioid burden in the postsurgical setting. Curr Med Res Opin. 2012;28(10):1609–1615
   PubMed Web of Science ®Google Scholar
• . Cohen SM. Extended pain relief trial utilizing infiltration of Exparel, a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open colectomy. J Pain Res. 2012;5:567–572
   PubMedGoogle Scholar
• . Marcet JE, Nfonsam VN, Larach S. An extended paIn relief trial utilizing the infiltration of a long-acting Multivesicular liPosome foRmulation Of bupiVacaine, EXPAREL (IMPROVE): a Phase IV health economic trial in adult patients undergoing ileostomy reversal. J Pain Res. 2013;6:549–555
   PubMed Web of Science ®Google Scholar
• . Vogel JD. Liposome bupivacaine (EXPAREL) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trial. J Pain Res. 2013;6:605–610
   PubMed Web of Science ®Google Scholar
• . Sternlicht A, Shapiro M, Robelen G, Vellayappan U, Tuerk IA. Initial findings using EXPAREL (bupivacaine liposome injectable suspension) via infiltration into the transversus abdominis plane (TAP) for postsurgical analgesia in robotic prostatectomy (RP) [abstract]. Presented at: Annual Fall Pain Meeting and Workshops of the American Society of Regional Anesthesia and Pain Medicine; November 15–18, 2012; Miami Beach, FL
   Google Scholar
• . Feierman DE, Kronenfeld M, Gupta PM, Younger N, Logvinskiy E. Evaluation of Exparel® use via infiltration into the transversus abdominis plane for prolonged postoperative analgesia in subjects undergoing open abdominal hernia repair. Poster presented at: Annual Meeting of the International Anesthesia Research Society; May 4–7, 2013; San Diego, CA
   Google Scholar
• . Apseloff G, Onel E, Patou G. Time to onset of analgesia following local infiltration of liposome bupivacaine in healthy volunteers: a randomized, single-blind, sequential cohort, crossover study. Int J Clin Pharmacol Ther. 2013;51:367–373
   PubMedGoogle Scholar
• . Ilfeld BM, Malhotra N, Furnish TJ, Donohue MC, Madison SJ. Liposomal bupivacaine as a single-injection peripheral nerve block: a dose-response study. Anesth Analg. 2013;117(5):1248–1256
   PubMed Web of Science ®Google Scholar
• . Viscusi ER, Candiotti KA, Onel E, Morren M, Ludbrook GL. The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers. Reg Anesth Pain Med. 2012;37(6):616–622
   PubMedGoogle Scholar
• . Hu D, Onel E, Singla N, Kramer WG, Hadzic A. Pharmacokinetic profile of liposome bupivacaine injection following a single administration at the surgical site. Clin Drug Investig. 2013;33(2):109–115
   PubMed Web of Science ®Google Scholar
• . Schmidt WK, Patou G, Joshi GP. Evaluating therapeutic benefit in postsurgical analgesia requires global assessment: an example from liposome bupivacaine in hemorrhoidectomy. Hosp Pract. 2012;40(1):160–165
   Google Scholar
• . Viscusi ER, Sinatra R, Onel E, Ramamoorthy SL. The safety of liposome bupivacaine, a novel local analgesic formulation [published online ahead of print February 26, 2013]. Clin J Pain
   Google Scholar
• . Baxter R, Bramlett K, Onel E, Daniels S. Impact of local administration of liposome bupivacaine for postsurgical analgesia on wound healing: a review of data from ten prospective, controlled clinical studies. Clin Ther. 2013;35(3):312–320
   PubMed Web of Science ®Google Scholar
• . Bergese SD, Onel E, Morren M, Morganroth J. Bupivacaine extended-release liposome injection exhibits a favorable cardiac safety profile. Reg Anesth Pain Med. 2012;37(2):145–151
   PubMedGoogle Scholar
• . Naseem A, Harada T, Wang D, . Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers. J Clin Pharmacol. 2012;52(9):1441–1447
   PubMedGoogle Scholar
• . Minkowitz HS, Onel E, Patronella CK, Smoot JD. A two-year observational study assessing the safety of DepoFoam bupivacaine after augmentation mammaplasty. Aesthet Surg J. 2012;32(2):186–193
   PubMedGoogle Scholar
• . Grit M, Crommelin DJA. Chemical stability of liposomes: implications for their physical stability. Chem Phys Lipids. 1993;64:3–18
   PubMed Web of Science ®Google Scholar